The Medicines and Healthcare products Regulatory Agency (MHRA) approved marketing authorisation for Mounjaro, a new therapy, to manage type 2 diabetes in adults. This approval comes after promising results from https://denisregt349517.mpeblog.com/72152281/groundbreaking-treatment-approved-in-the-uk-for-type-2-diabetes